Immunic, Inc. (IMUX)

Immunic Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	55.31	35.67	46.67	106.75	86.86	127.45
Cash & Short-Term Investments	55.31	35.67	46.67	106.75	86.86	127.45
Cash Growth	-30.60%	-23.58%	-56.27%	22.89%	-31.85%	333.97%
Other Current Assets	4.53	3.66	5.86	19.12	18.13	6.29
Total Current Assets	59.84	39.33	52.53	125.86	104.99	133.75
Net Property, Plant & Equipment	1.59	1.54	1.77	1.85	1.1	1.1
Goodwill	-	-	-	-	32.97	32.97
Other Long-Term Assets	-	-	-	0.04	0.04	0.04
Total Assets	61.43	40.87	54.3	127.75	139.1	167.86
Accounts Payable	7.89	7.85	5.1	4.28	3.75	3.7
Accrued Expenses	18.11	12.91	18.66	7.99	7.07	4.32
Other Current Liabilities	1.31	1.42	0.97	0.81	0.59	0.38
Total Current Liabilities	27.31	22.18	24.73	13.08	11.4	8.4
Long-Term Leases	0.21	0.26	0.64	0.99	0.58	0.68
Total Long-Term Liabilities	0.21	0.26	0.64	0.99	0.58	0.68
Total Liabilities	27.52	22.44	25.37	14.07	11.99	9.08
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-in Capital	595.07	525.61	436.06	427.93	324.24	266.82
Accumulated Other Comprehensive Income	2.53	4.21	3.76	3.04	-0.25	-4.11
Retained Earnings	-563.69	-511.4	-410.89	-317.28	-196.87	-103.93
Shareholders' Equity	33.91	18.43	28.93	113.68	127.12	158.79
Total Liabilities & Equity	61.43	40.87	54.3	127.75	139.1	167.86
Total Debt	0.21	0.26	0.64	0.99	0.58	0.68
Net Cash (Debt)	55.11	35.4	46.04	105.75	86.28	126.77
Net Cash Growth	55.65%	-23.09%	-56.47%	22.57%	-31.94%	339.44%
Net Cash Per Share	0.51	0.35	1.04	3.32	3.65	8.09
Book Value	33.91	18.43	28.93	113.68	127.12	158.79
Book Value Per Share	0.31	0.18	0.65	3.57	5.37	10.14
Tangible Book Value	33.91	18.43	28.93	113.68	94.15	125.82
Tangible Book Value Per Share	0.31	0.18	0.65	3.57	3.98	8.03

Updated Aug 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q